Literature DB >> 6275127

Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities.

P A Furman, D M Coen, M H St Clair, P A Schaffer.   

Abstract

The biochemical properties of four acyclovir-resistant mutants are described. Two of these mutants, PAAr5 and BWr, specified nucleotidyl transferase (DNA polymerase) activities which were less sensitive to inhibition by acyclovir triphosphate than their wild-type counterparts. Another mutant, IUdRr, exhibited reduced ability to phosphorylate acyclovir. The fourth mutant, ACGr4, both induced an altered DNA polymerase and failed to phosphorylate appreciable amounts of acyclovir. BWr, a new acyclovir-resistant mutant derived from the Patton strain of herpes simplex virus type 1, induced a DNA polymerase resistant to inhibition by acyclovir triphosphate, but, unlike the polymerases induced by PAAr5 and ACGr4, still sensitive to phosphonoacetic acid. Resistance of BWr to acyclovir mapped close to the PAAr locus and was separable from mutations in the herpes simplex virus thymidine kinase gene by recombination analysis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275127      PMCID: PMC256706     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Identification of the herpes simplex virus DNA polymerase gene.

Authors:  D J Purifoy; R B Lewis; K L Powell
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

2.  Physical and genetic analysis of the herpes simplex virus DNA polymerase locus.

Authors:  P Chartrand; C S Crumpacker; P A Schaffer; N M Wilkie
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

3.  Characterization of herpes simplex virus-induced deoxyribonucleic acid polymerase.

Authors:  A Weissbach; S C Hong; J Aucker; R Muller
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

4.  Active center of DNA polymerase.

Authors:  A Kornberg
Journal:  Science       Date:  1969-03-28       Impact factor: 47.728

5.  Relative potencies of anti-herpes compounds.

Authors:  P Collins; D J Bauer
Journal:  Ann N Y Acad Sci       Date:  1977-03-04       Impact factor: 5.691

6.  Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate.

Authors:  P A Furman; M H St Clair; J A Fyfe; J L Rideout; P M Keller; G B Elion
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

7.  Physical mapping of paar mutations of herpes simplex virus type 1 and type 2 by intertypic marker rescue.

Authors:  P Chartrand; N D Stow; M C Timbury; N M Wilkie
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

8.  Genetics of resistance to phosphonoacetic acid in strain KOS of herpes simplex virus type 1.

Authors:  J T Jofre; P A Schaffer; D S Parris
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

9.  In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).

Authors:  K O Smith; W L Kennell; R H Poirier; F T Lynd
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

10.  Herpes simplex virus resistance and sensitivity to phosphonoacetic acid.

Authors:  R W Honess; D H Watson
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

View more
  39 in total

1.  Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.

Authors:  G B Elion
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

2.  Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.

Authors:  M N Ellis; P M Keller; J A Fyfe; J L Martin; J F Rooney; S E Straus; S N Lehrman; D W Barry
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

3.  Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.

Authors:  S Kit; M Sheppard; H Ichimura; S Nusinoff-Lehrman; M N Ellis; J A Fyfe; H Otsuka
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 4.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

5.  Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex viruses.

Authors:  M N Ellis; D C Lobe; T Spector
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

6.  Mechanism of resistance of human immunodeficiency virus type 1 to 2',3'-dideoxyinosine.

Authors:  J L Martin; J E Wilson; R L Haynes; P A Furman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Cooperative effects between two acyclovir resistance loci in herpes simplex virus.

Authors:  G Darby; M J Churcher; B A Larder
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

Review 8.  Antiherpes drugs: promises and pitfalls.

Authors:  E de Clercq
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

9.  Resistance of herpes simplex virus to 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine: physical mapping of drug synergism within the viral DNA polymerase locus.

Authors:  C S Crumpacker; P N Kowalsky; S A Oliver; L E Schnipper; A K Field
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

10.  Inhibition of cellular alpha DNA polymerase and herpes simplex virus-induced DNA polymerases by the triphosphate of BW759U.

Authors:  M H St Clair; W H Miller; R L Miller; C U Lambe; P A Furman
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.